Mirtazapina Qualigen (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, leading to increased release of norepinephrine. It also antagonises postsynaptic 5‑HT2 and 5‑HT3 serotonin receptors and H1 histamine receptors. This combined activity raises synaptic serotonin and norepinephrine levels while providing antihistaminic effects, which together produce antidepressant and sedative actions.

The appropriate dose of mirtazapine is determined by the prescribing clinician based on the individual’s clinical condition, response, and tolerability. Dosage may be started at a low level and titrated upward as needed, but exact regimens should only be set by a qualified healthcare professional.

The safety of mirtazapine in pregnancy and lactation has not been definitively established, and the product is classified with an unknown pregnancy category. Clinicians should weigh potential benefits against possible risks and consider alternative therapies when treating pregnant or nursing patients.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Mirtazapina Qualigen. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapine belongs to the NaSSA class, whereas SSRIs primarily inhibit serotonin reuptake. Mirtazapine’s antagonism of certain serotonin receptors and histamine receptors often results in sedation and weight gain, which can be advantageous for patients with insomnia or low appetite. SSRIs tend to have a different side‑effect profile, including sexual dysfunction and gastrointestinal upset.

Mirtazapina Qualigen should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, direct sunlight and excessive heat to maintain stability and potency throughout its shelf life.

Mirtazapina Qualigen is taken orally, usually once daily in the evening to take advantage of its sedative effect. The tablet should be swallowed whole with water and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include the potential for agranulocytosis or severe neutropenia, rare skin reactions such as Stevens‑Johnson syndrome, and the emergence or worsening of suicidal thoughts, particularly during the early weeks of therapy. Prompt medical attention is required if any of these events occur.

Mirtazapine should be avoided in patients who have a known hypersensitivity to the drug or any of its excipients. It is also contraindicated in individuals currently receiving monoamine oxidase inhibitors (MAOIs) or who have taken an MAOI within the past 14 days due to the risk of severe serotonin syndrome.